Their study revealed that T2D patients exhibit a significant decrease in the nuclear bioactive pGR-S211 protein levels, suggesting impaired GR signaling in PBMCs of T2D patients [126]. This evidence concerns the gene NR3C1 and type 2 diabetes mellitus.